Eliquis $10 co-pay card / Eliquis discount card

Go directly to the Eliquis savings article

Since being FDA approved in 2012, Eliquis has become an excellent option for the prevention of stroke in patients with nonvalvular atrial fibrillation. Eliquis was approved based on the results of the 2011 ARISTOTLE Trial. During this trial, over 18,000 patients were studied. Eliquis was compared to Warfarin over a mean period of 1.8 years. During this study Eliquis was shown to be superior to Warfarin in reducing risk of stroke. Patients taking Eliquis also showed significantly less risk for major bleeding compared to Warfarin.

Over the last 6 years Eliquis has continued to demonstrate its effectiveness at reducing risk of stroke while maintain a lower risk for significant bleeding. Because of its continued success, Eliquis is now advertised as the #1 prescribed blood thinner by Cardiologists.

Dr. Percy Morales (DrAfib.com) manages many patients on Eliquis, but it is not the right fit for everyone. One major reason for this is due to cost. Like many newer medications, patients taking Eliquis may end up with significant out of pocket expenses.

This article offers three proven ways to save money on your Eliquis prescription, including an Eliquis coupon (eliquis copay card), an Eliquis patient assistance program, and an Eliquis free trial.

Read the full article here

--

--

Robert Scott
Robert Scott

Written by Robert Scott

0 Followers

I post articles and answers from Dr. Percy F. Morales, M.D., on the subject of atrial fibrillation (Afib).

No responses yet